Vellum Health Closes Series A Round Led by FCA Venture Partners, Launches Mobile IV Care Platform

Vellum Health完成由FCA Venture Partners领投的A轮融资，推出移动IV护理平台

AUSTIN, Texas, June 26, 2025-- Vellum Health, the mobile healthcare platform delivering advanced intravenous (IV) services at the bedside, today announced the close of its Series A funding round. The round was led by FCA Venture Partners, with participation from Green Park & Golf Ventures, and follow-on investment from seed round angel investors..

德克萨斯州奥斯汀，2025年6月26日——Vellum Health，这家在床边提供先进静脉注射（IV）服务的移动医疗平台，今天宣布完成了其A轮融资。本轮融资由FCA Venture Partners领投，Green Park & Golf Ventures参与，并获得了种子轮天使投资者的后续投资。

The company is also announcing the launch of its new brand—Vellum Health—which unifies a portfolio of acquired vascular access companies into a single, tech-enabled care delivery platform.

该公司还宣布推出其新品牌——Vellum Health，该品牌将一系列收购的血管通路公司整合到一个单一的技术支持护理交付平台中。

Vellum Health provides mobile IV access, infusion therapy, and on-site transfusion services to patients in skilled nursing facilities, long-term acute care centers, and homes. By enabling hospitals, payors, and post-acute providers to extend high-quality care into lower-cost, more convenient settings, Vellum reduces unnecessary hospitalizations and improves patient outcomes..

Vellum Health 为熟练护理机构、长期急症护理中心和家庭中的患者提供移动静脉注射、输液治疗和现场输血服务。通过使医院、支付方和急性后期护理提供者能够将高质量护理扩展到成本更低、更方便的环境中，Vellum 减少了不必要的住院并改善了患者的治疗效果。

“This funding marks a pivotal milestone for our company,” said Tyler Payne, CEO of Vellum Health. “It allows us to scale nationally while launching a brand that represents our commitment to smarter, value-driven care. Our model delivers expert care directly to the bedside—anytime, anywhere.”

“这笔资金标志着我们公司的一个关键里程碑，”Vellum Health首席执行官泰勒·佩恩表示。“它使我们能够在全国范围内扩展，同时推出一个代表我们对更智能、价值驱动型护理承诺的品牌。我们的模式能够随时随地将专业护理直接送到病床边。”

With this round of funding, Vellum Health will accelerate its expansion into new markets and further invest in its proprietary AI-powered technology platform. This platform enables secure EMR integration, intelligent care navigation, dynamic documentation, and proactive patient identification—serving as the connective tissue between providers, payors, and clinical teams..

通过此轮融资，Vellum Health 将加速拓展新市场，并进一步投资于其专有的 AI 技术平台。该平台能够实现安全的电子病历集成、智能护理导航、动态文档记录和主动患者识别，成为连接医疗服务提供者、支付方和临床团队的关键纽带。

'Vellum is solving real operational and clinical challenges with a patient-centered, mobile-first model,' said Matt King, Managing Partner at FCA Venture Partners. 'We’re excited to support their growth and believe their model is uniquely positioned to meet the needs of an evolving healthcare landscape.'.

“Vellum 通过以患者为中心、移动端优先的模式，解决了实际的运营和临床挑战，”FCA Venture Partners 的管理合伙人 Matt King 表示，“我们非常高兴支持他们的成长，并相信他们的模式在不断发展的医疗保健领域中具有独特的定位。”

“Our team of early investors saw something powerful in Vellum’s vision from the very beginning,” said Michael Sanderson, a seed round investor. “We’re proud to continue supporting this next phase of growth as Vellum transforms how and where care is delivered. Their ability to combine technology, clinical quality, and operational excellence is exactly what modern healthcare needs.”.

“我们的早期投资者团队从一开始就看到了Vellum愿景中的强大潜力，”种子轮投资者迈克尔·桑德森表示，“我们很自豪能继续支持Vellum进入增长的下一个阶段，因为他们正在变革医疗保健的提供方式和地点。他们将技术、临床质量和运营卓越性相结合的能力，正是现代医疗保健所需要的。”

Vellum Health currently serves facilities and home-based patients across multiple states and partners with payors, hospitals, and post-acute care providers to extend access to complex care without requiring hospitalization.

Vellum Health 目前在多个州为医疗机构和居家患者提供服务，并与支付方、医院和急性后期护理机构合作，在无需住院的情况下扩展对复杂护理的获取途径。

About Vellum Health

关于Vellum Health

Vellum Health is the first and only platform for on-demand IV enablement and therapy that integrates advanced technology, highly trained clinicians, and mobile service delivery. Vellum’s offerings include mobile IV access (PIVs, Midlines, PICCs), on-demand IV infusions for hydration, infection, cognition, and nutrition, on-site blood transfusions, and AI-powered care coordination.

Vellum Health 是首个也是唯一一个按需提供静脉通路和治疗的平台，整合了先进技术、高度专业化的临床医生以及移动服务交付。Vellum 的服务包括移动静脉通路（外周静脉导管、中线导管、PICC）、按需静脉输液（用于补水、感染、认知和营养）、现场输血以及由人工智能驱动的护理协调。

By aligning with health systems, payors, and senior care organizations, Vellum helps deliver safer, faster, and more cost-effective treatment wherever patients are..

通过与卫生系统、支付方和老年护理机构合作，Vellum帮助在患者所在的地方提供更安全、更快、更具成本效益的治疗。

To learn more, visit vellum.health or contact info@vellum.health

要了解更多信息，请访问 vellum.health 或联系 info@vellum.health

About FCA Venture Partners:

关于FCA风险合作伙伴：

FCA Venture Partners is a venture capital firm investing in companies transforming healthcare through innovative technology and services that improve patient outcomes, empower providers, lower costs, and redefine how care is delivered. FCA manages over $285 million and invests across the Series Seed to Series B stages.

FCA Venture Partners是一家风险投资公司，专注于投资通过创新技术和优质服务改善医疗保健行业的公司，这些技术和方案能够提升患者疗效、赋能医疗服务提供者、降低成本，并重新定义护理的提供方式。FCA管理着超过2.85亿美元的资金，投资阶段涵盖种子轮到B轮融资。

FCA brings portfolio companies valuable healthcare insights, connections, and board-level experience to accelerate growth and build disruptive and sustainable businesses. Based in Nashville and Charlotte, the FCA team has a decades-long track record including more than 60 investments in the rapidly changing healthcare industry..

FCA为旗下投资组合公司带来宝贵的医疗保健行业洞察、人脉和董事会层面的经验，以加速增长并打造颠覆性且可持续发展的企业。FCA团队位于纳什维尔和夏洛特，拥有长达数十年的成功记录，其中包括在快速变化的医疗保健行业进行了60多次投资。

Contact:

联系：

Media Contact:

媒体联系人：

press@vellum.health

press@vellum.health